PDS Biotechnology Corp (PDSB) stock
PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.89−0.03 (-3.28%)
Close on Nov 17, 2026Market cap $50.03MP/E –Yield –
PDS Biotechnology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
PDS Biotechnology's enterprise value was $51.44M on Nov 11, 2026, against $10.58M a year earlier. Over the last 5 years it ranged from $3.52M to $304.01M, with a median of $59.59M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $51.44M | +388.8% |
| 2025 | Dec 31, 2025 | $10.52M | +2.5% |
| 2024 | Dec 31, 2024 | $10.27M | -89.7% |
| 2023 | Dec 29, 2023 | $99.86M | -67.2% |
| 2022 | Dec 30, 2022 | $304.01M | +89.3% |
| 2021 | Dec 31, 2021 | $160.58M | +1033.2% |
| 2020 | Dec 31, 2020 | $14.17M | – |
| 2019 | Dec 31, 2019 | -$3.42M | -117.1% |
| 2018 | Dec 31, 2018 | $19.97M | -95.8% |
| 2017 | Dec 29, 2017 | $480.99M | -21.2% |
| 2016 | Dec 30, 2016 | $610.10M | – |
| 2015 | Dec 31, 2015 | -$10.67M | – |
See a number that looks wrong?